<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230907059376N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-14</date_registration>
      <primary_sponsor>Khyber Teaching Hospital, Peshawar</primary_sponsor>
      <public_title>Importance of timing in craniotomy in Spontaneous intracereberal haemorrhage: experience in tertiary care hospital</public_title>
      <acronym></acronym>
      <scientific_title>Importance of timing in craniotomy in Spontaneous intracereberal haemorrhage</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75460</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, we implemented randomization to ensure unbiased allocation of participants to treatment groups. We employed block randomization, grouping participants based on specific criteria, and then randomly assigning them to treatment groups within each block. This method helps maintain balance across treatment groups and controls for potential confounding variables. Randomization was carried out at the individual level, ensuring each participant had an equal chance of being assigned to any treatment group, Blinding description: Outcome assessors were blinded to treatment assignments through the utilization of sealed envelopes containing group allocations, ensuring impartial evaluation of study outcomes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Intracranial Haemorrhage.</hc_freetext>
      <i_freetext>Intervention 1: Control group: This approach involved providing standard medical care without immediate surgical intervention. Specifically, patients received routine medical attention aimed at stabilizing their condition and managing symptoms. This included pharmacological interventions such as medications to control blood pressure, pain management, and other supportive measures. However, crucially, these patients did not undergo surgical procedures such as craniotomy for hematoma evacuation.Additionally, patients in the medical management group did not undergo continuous monitoring of vital signs and neurological status, nor was there a predefined cutoff point for initiating surgical intervention based on changes in these parameters. Instead, they were managed conservatively with medical therapy alone, with interventions for complications initiated as clinically indicated rather than preemptively. Intervention 2: Intervention group: Patients assigned to the early surgical intervention group received a more aggressive treatment approach involving prompt surgical intervention within 24 hours of symptom onset. This involved performing a craniotomy procedure aimed at evacuating the hematoma and achieving control of the bleeding source. The surgical intervention was conducted promptly to minimize the potential deleterious effects of the hematoma, such as increased intracranial pressure and compression of vital brain structures.Unlike the medical management group, patients in the early surgical intervention group underwent surgical procedures aimed at directly addressing the underlying pathology causing their symptoms. This proactive approach aimed to expedite hematoma evacuation and prevent further neurological deterioration associated with delayed surgical intervention.Following the surgical procedure, patients in both groups were regularly monitored and followed up with imaging studies to assess the efficacy of the treatment approach. This allowed clinicians to evaluate the resolution of the hematoma, assess for any complications related to the intervention, and track the overall clinical progress of the patients over time.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data will be provided under the title importance of timing in craniotomy in Spontaneous intracereberal haemorrhage: experience in a Tertiary care hospital

When:
Data will be available after approval of RCT

To whom:
Data will be available to neurosurgeons and medical students

Conditions:
Data will be used after approvla from principle author

Where to obtain:
Data will be obtained through email to principle author
Muhammad Idris Khan
idrisnsw83@gmail.com

How to obtain:
Process is simple. Just the seeker have to email the author

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahboob Khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Afridi medical complex tehkal payan, University Rd, Tehkal, Peshawar, Khyber Pakhtunkhwa</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25150</zip>
        <telephone>+92 91 5711751</telephone>
        <email>mehboob509@gmail.com</email>
        <affiliation>Afridi Medical Complex, Peshawar</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahboob Khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Afridi medical complex tehkal payan, University Rd, Tehkal, Peshawar, Khyber Pakhtunkhwa</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25150</zip>
        <telephone>+92 91 5711751</telephone>
        <email>mehboob509@gmail.com</email>
        <affiliation>Afridi Medical Complex, Peshawar</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients age range from 18 to 70 years
Patients of both genders, i.e. male and female
Patients who were diagnosed with spontaneous ICH and confirmed by neuroimaging to have a Glasgow Coma Scale (GCS) score of 5-18</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who have traumatic intracerebral bleeding
All the cases requiring surgical intervention
Deep-seated bleeding, coagulopathy, pregnancy, or pre-existing neurological conditions that could affect results were excluded from this study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I62.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Nontraumatic intracranial hemorrhage, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: This approach involved providing standard medical care without immediate surgical intervention. Specifically, patients received routine medical attention aimed at stabilizing their condition and managing symptoms. This included pharmacological interventions such as medications to control blood pressure, pain management, and other supportive measures. However, crucially, these patients did not undergo surgical procedures such as craniotomy for hematoma evacuation.Additionally, patients in the medical management group did not undergo continuous monitoring of vital signs and neurological status, nor was there a predefined cutoff point for initiating surgical intervention based on changes in these parameters. Instead, they were managed conservatively with medical therapy alone, with interventions for complications initiated as clinically indicated rather than preemptively.</i_keyword>
      <i_keyword>Intervention group: Patients assigned to the early surgical intervention group received a more aggressive treatment approach involving prompt surgical intervention within 24 hours of symptom onset. This involved performing a craniotomy procedure aimed at evacuating the hematoma and achieving control of the bleeding source. The surgical intervention was conducted promptly to minimize the potential deleterious effects of the hematoma, such as increased intracranial pressure and compression of vital brain structures.Unlike the medical management group, patients in the early surgical intervention group underwent surgical procedures aimed at directly addressing the underlying pathology causing their symptoms. This proactive approach aimed to expedite hematoma evacuation and prevent further neurological deterioration associated with delayed surgical intervention.Following the surgical procedure, patients in both groups were regularly monitored and followed up with imaging studies to assess the efficacy of the treatment approach. This allowed clinicians to evaluate the resolution of the hematoma, assess for any complications related to the intervention, and track the overall clinical progress of the patients over time.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Functional Independance measure. Timepoint: The measurement was taken at baseline and after 90 days. Method of measurement: A modified Ranken scale was used to assess the functional independance measure.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khyber Teaching Hospital, Peshawar</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-12</approval_date>
        <contact_name>Ethical committe of khyber teaching hospital</contact_name>
        <contact_address>University Rd, Rahat Abad, Peshawar, Khyber Pakhtunkhwa, Pakistan Peshawar Khyber Pakhtunkhwa Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
